PCM
TCRR

Prelude Capital Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Prelude Capital Management’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,715
Closed -$30K – 1656
2022
Q3 		$30K Sell
16,715
-19,785
-54% -$35.5K ﹤0.01% 1205
2022
Q2 		$106K Sell
36,500
-17,200
-32% -$50K ﹤0.01% 1198
2022
Q1 		$148K Buy
53,700
+17,400
+48% +$48K ﹤0.01% 1058
2021
Q4 		$169K Buy
+36,300
New +$169K ﹤0.01% 1258